Variant report

Variant	esv3373486
Chromosome Location	chr11:48001001-48003549
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:484)
CpG islands
(count:490)
Chromatin interactive
region (count:6)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:484 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr11:48001120-48001869	H1-hESC	embryonic stem cell:	n/a	n/a
2	BHLHE40	chr11:48002001-48002473	K562	blood:	n/a	chr11:48002237-48002253 chr11:48002138-48002154 chr11:48002104-48002120 chr11:48002375-48002391 chr11:48002146-48002162 chr11:48002240-48002256
3	BHLHE40	chr11:48002116-48002526	GM12878	blood:	n/a	chr11:48002237-48002253 chr11:48002138-48002154 chr11:48002375-48002391 chr11:48002146-48002162 chr11:48002240-48002256
4	BHLHE40	chr11:48002688-48003004	K562	blood:	n/a	n/a
5	BHLHE40	chr11:48003267-48003524	K562	blood:	n/a	n/a
6	BHLHE40	chr11:48000908-48001210	K562	blood:	n/a	n/a
7	BHLHE40	chr11:48003311-48003830	GM12878	blood:	n/a	n/a
8	BHLHE40	chr11:48002877-48002924	GM12878	blood:	n/a	n/a
9	CCNT2	chr11:48001687-48003494	K562	blood:	n/a	chr11:48002660-48002669 chr11:48002062-48002071 chr11:48003223-48003232
10	CEBPB	chr11:48002707-48003360	Hela-S3	cervix:	n/a	n/a
11	CEBPB	chr11:48002055-48002351	Hela-S3	cervix:	n/a	n/a
12	CHD1	chr11:48002367-48002442	GM12878	blood:	n/a	n/a
13	CHD1	chr11:48002832-48002961	GM12878	blood:	n/a	n/a
14	CHD1	chr11:48002670-48003635	IMR90	lung:	n/a	n/a
15	CHD1	chr11:48002971-48003019	H1-hESC	embryonic stem cell:	n/a	n/a
16	CHD2	chr11:48001553-48003496	Hela-S3	cervix:	n/a	chr11:48001912-48001922
17	CHD2	chr11:48002116-48002201	K562	blood:	n/a	n/a
18	CHD2	chr11:48000967-48001044	HepG2	liver:	n/a	n/a
19	CREB1	chr11:48001883-48002477	A549	lung:	n/a	n/a
20	CTBP2	chr11:48000968-48001868	H1-hESC	embryonic stem cell:	n/a	n/a
21	CTCF	chr11:48002840-48002990	GM12878	blood:	n/a	n/a
22	CTCF	chr11:48002763-48003092	K562	blood:	n/a	chr11:48002992-48003005
23	CTCF	chr11:48001040-48001190	HBMEC	blood vessel:	n/a	n/a
24	CTCF	chr11:48002840-48002990	Hela-S3	cervix:	n/a	n/a
25	CTCF	chr11:48002840-48002990	GM12864	blood:	n/a	n/a
26	CTCF	chr11:48000980-48001156	MCF-7	breast:	n/a	n/a
27	CTCF	chr11:48002840-48002990	MCF-7	breast:	n/a	n/a
28	CTCF	chr11:48002860-48003010	GM12867	blood:	n/a	chr11:48002992-48003005
29	CTCF	chr11:48002780-48002930	NHDF-neo	bronchial:	n/a	n/a
30	CTCF	chr11:48002880-48003030	AG04450	lung:	n/a	chr11:48002992-48003005
31	CTCF	chr11:48002800-48002950	AG04449	skin:	n/a	n/a
32	CTCF	chr11:48002800-48002950	NHLF	lung:	n/a	n/a
33	CTCF	chr11:48001220-48001370	Hela-S3	cervix:	n/a	n/a
34	CTCF	chr11:48002991-48002995	H1-hESC	embryonic stem cell:	n/a	n/a
35	CTCF	chr11:48000940-48001090	HEK293	kidney:	n/a	n/a
36	CTCF	chr11:48002820-48002970	Caco-2	colon:	n/a	n/a
37	CTCF	chr11:48001008-48001137	Hela-S3	cervix:	n/a	n/a
38	CTCF	chr11:48002880-48003030	HA-sp	spinal cord:	n/a	chr11:48002992-48003005
39	CTCF	chr11:48000980-48001130	HRPEpiC	eye:	n/a	n/a
40	CTCF	chr11:48002860-48003010	HVMF	connective:	n/a	chr11:48002992-48003005
41	CTCF	chr11:48002736-48003095	GM12878	blood:	n/a	chr11:48002992-48003005
42	CTCF	chr11:48002760-48002910	K562	blood:	n/a	n/a
43	CTCF	chr11:48002780-48002930	SAEC	small airway:	n/a	n/a
44	CTCF	chr11:48002876-48002995	GM10248	blood:	n/a	n/a
45	CTCF	chr11:48000900-48001050	HAc	cerebellar:	n/a	n/a
46	CTCF	chr11:48002800-48002950	GM12871	blood:	n/a	n/a
47	CTCF	chr11:48003001-48003005	GM19239	blood:	n/a	n/a
48	CTCF	chr11:48002820-48002970	NHDF-neo	bronchial:	n/a	n/a
49	CTCF	chr11:48002783-48003001	K562	blood:	n/a	n/a
50	CTCF	chr11:48002840-48002990	HFF	foreskin:	n/a	n/a

(count:490 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:48002566-48002616	HepG2	liver:	n/a
2	chr11:48001669-48001719	NB4	blood:	n/a
3	chr11:48002566-48002616	HepG2	liver:	n/a
4	chr11:48001669-48001719	NB4	blood:	n/a
5	chr11:48001669-48001719	HRPEpiC	eye:	n/a
6	chr11:48001940-48001990	GM06990	blood:	n/a
7	chr11:48002566-48002616	HMEC	breast:	n/a
8	chr11:48003065-48003115	PANC-1	pancreas:	n/a
9	chr11:48003169-48003219	HRE	kidney:	n/a
10	chr11:48003169-48003219	K562	blood:	n/a
11	chr11:48003065-48003115	AG10803	skin:	n/a
12	chr11:48003169-48003219	LNCaP	prostate:	n/a
13	chr11:48002566-48002616	T-47D	breast:	n/a
14	chr11:48003169-48003219	MCF-7	breast:	n/a
15	chr11:48001940-48001990	HCPEpiC	choroid plexus:	n/a
16	chr11:48001669-48001719	Jurkat	blood:	n/a
17	chr11:48001761-48001811	ProgFib	skin:	n/a
18	chr11:48001954-48002004	BE2_C	brain:	n/a
19	chr11:48001940-48001990	HPAEpiC	pulmonary alveolar:	n/a
20	chr11:48001835-48001885	AoSMC	blood vessel:	n/a
21	chr11:48002566-48002616	HEK293	kidney:	embryo
22	chr11:48001954-48002004	AG09309	skin:	n/a
23	chr11:48003065-48003115	SK-N-MC	brain:	n/a
24	chr11:48002566-48002616	GM12878	blood:	n/a
25	chr11:48002566-48002616	MCF10A-Er-Src	breast:	n/a
26	chr11:48001940-48001990	PrEC	prostate:	n/a
27	chr11:48001940-48001990	Hela-S3	cervix:	n/a
28	chr11:48001954-48002004	SK-N-SH	brain:	n/a
29	chr11:48001669-48001719	AG04450	lung:	fetal
30	chr11:48001669-48001719	NT2-D1	testis:	n/a
31	chr11:48003065-48003115	NB4	blood:	n/a
32	chr11:48001669-48001719	HNPCEpiC	eye:	n/a
33	chr11:48001669-48001719	HUVEC	blood vessel:	n/a
34	chr11:48001835-48001885	Caco-2	colon:	n/a
35	chr11:48003169-48003219	NHDF-neo	bronchial:	n/a
36	chr11:48002566-48002616	ovcar-3	ovarian:	n/a
37	chr11:48001940-48001990	HUVEC	blood vessel:	n/a
38	chr11:48003065-48003115	GM12891	blood:	n/a
39	chr11:48001954-48002004	PFSK-1	brain:	n/a
40	chr11:48003065-48003115	GM12878	blood:	n/a
41	chr11:48003065-48003115	MCF10A-Er-Src	breast:	n/a
42	chr11:48003169-48003219	PANC-1	pancreas:	n/a
43	chr11:48001954-48002004	LNCaP	prostate:	n/a
44	chr11:48001940-48001990	SAEC	small airway:	n/a
45	chr11:48002566-48002616	HAEpiC	amniotic membrane:	n/a
46	chr11:48001835-48001885	HL-60	blood:	n/a
47	chr11:48001954-48002004	PrEC	prostate:	n/a
48	chr11:48001669-48001719	AG10803	skin:	n/a
49	chr11:48003065-48003115	AG04450	lung:	fetal
50	chr11:48001669-48001719	PFSK-1	brain:	n/a

(count:6 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr11:48003107..48006285-chr11:48013442..48016525,3	MCF-7	breast:
2	chr11:48002635..48003533-chr11:48130431..48131591,3	MCF-7	breast:
3	chr11:47998626..48001544-chr11:48011540..48013257,2	MCF-7	breast:
4	chr11:48000640..48001500-chr11:48131020..48132149,3	MCF-7	breast:
5	chr11:47955684..47956212-chr11:48000981..48001494,2	MCF-7	breast:
6	chr11:48002531..48005255-chr11:48006333..48009338,3	K562	blood:

No data

Variant related genes	Relation type
PTPRJ	TF binding region
PTPRJ	CpG island

Extended variants
information (count: 61 )
Associated
traits (count: 62 )

Variant overlapped rSNPs/rCNVs (count:61 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs558657111	chr11:48001029-48001030	Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs151233291	chr11:48001082-48001083	Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs535593904	chr11:48001087-48001088	Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs140417440	chr11:48001120-48001121	Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs566060722	chr11:48001136-48001137	Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs184974212	chr11:48001157-48001158	Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs554097054	chr11:48001177-48001178	Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs577253394	chr11:48001238-48001239	Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs539572285	chr11:48001259-48001260	Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs533719733	chr11:48001298-48001299	Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs576224329	chr11:48001299-48001300	Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs556092462	chr11:48001314-48001315	Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs145527360	chr11:48001325-48001326	Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs189808650	chr11:48001417-48001418	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs541581118	chr11:48001458-48001459	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs73462867	chr11:48001471-48001472	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer Genic enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs571691790	chr11:48001475-48001476	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs540672362	chr11:48001492-48001493	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs111293538	chr11:48001530-48001531	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs564392247	chr11:48001543-48001544	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs370616015	chr11:48001599-48001600	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs77587162	chr11:48001602-48001603	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs576722421	chr11:48001734-48001735	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs377624963	chr11:48001743-48001744	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs550316604	chr11:48001784-48001785	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
26	rs563753761	chr11:48001802-48001803	Active TSS Weak transcription Transcr. at gene 5' and 3' Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
27	rs371632524	chr11:48002106-48002107	Active TSS Weak transcription Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs112643179	chr11:48002194-48002195	Active TSS Weak transcription Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs182016809	chr11:48002342-48002343	Active TSS Weak transcription Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs184700061	chr11:48002354-48002355	Active TSS Weak transcription Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs529521533	chr11:48002572-48002573	Active TSS Weak transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs549486402	chr11:48002611-48002612	Active TSS Transcr. at gene 5' and 3' Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
33	rs566221989	chr11:48002632-48002633	Active TSS Transcr. at gene 5' and 3' Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
34	rs544983491	chr11:48002671-48002672	Active TSS Transcr. at gene 5' and 3' Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
35	rs1228012	chr11:48002723-48002724	Active TSS Transcr. at gene 5' and 3' Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
36	rs7482168	chr11:48002727-48002728	Active TSS Transcr. at gene 5' and 3' Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
37	rs551800146	chr11:48002778-48002779	Active TSS Transcr. at gene 5' and 3' Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
38	rs539086323	chr11:48002780-48002781	Active TSS Transcr. at gene 5' and 3' Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
39	rs570683704	chr11:48002809-48002810	Bivalent/Poised TSS Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
40	rs539365887	chr11:48002868-48002869	Bivalent/Poised TSS Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
41	rs113306937	chr11:48002900-48002901	Bivalent/Poised TSS Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
42	rs12287121	chr11:48002901-48002902	Bivalent/Poised TSS Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs12287032	chr11:48002906-48002907	Bivalent/Poised TSS Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs543102072	chr11:48002907-48002908	Bivalent/Poised TSS Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
45	rs555748293	chr11:48002956-48002957	Bivalent/Poised TSS Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
46	rs535300921	chr11:48003006-48003007	Bivalent/Poised TSS Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs555034059	chr11:48003028-48003029	Bivalent/Poised TSS Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs386753272	chr11:48003195-48003196	Bivalent/Poised TSS Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs1681611	chr11:48003196-48003197	Bivalent/Poised TSS Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs563756398	chr11:48003276-48003277	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:62)

Disease	PMID	Source
Parathyroid adenoma	22454399	CNVD
Medulloblastoma	21979893	CNVD
Chordoma	21602918	CNVD
Breast cancer	21949216	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	19222835	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Beckwith-Wiedemann syndrome	21518781	CNVD
Wilms tumour	21518781	CNVD
Hepatoblastoma	21518781	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Wilms tumour	21544195	CNVD
Gastric cancer	17908304	CNVD
Multiple myeloma	20724749	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Non-small cell lung cancer	21385341	CNVD
Intellectual disability	22102821	CNVD
Renal cell carcinoma	18194544	CNVD
Breast cancer	17603634	CNVD
Chordoma	18071362	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Potocki-Shaffer syndrome	19222835	CNVD
WAGR syndrome	19222835	CNVD
small cell lung cancer	20016488	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Myelofibrosis	22110671	CNVD
Melanoma	18172304	CNVD
Intracranial ependymoma	16609018	CNVD
Myxofibrosarcoma	16751306	CNVD
Potocki-Shaffer syndrome	22470819	CNVD
Neurodevelopmental disorder	22521361	CNVD
Breast cancer	16608533	CNVD
Hirschsprung''s Disease	21712996	CNVD
Follicular lymphoma	20505157	CNVD
Colorectal cancer	21128281	CNVD
Breast cancer	20409316	CNVD
Neurocytoma	17123091	CNVD
Central neurocytomas	17123091	CNVD
Multiple myeloma	16616336	CNVD
Cancer	17160897	CNVD
Mantle cell lymphoma	19029149	CNVD
Glioblastoma multiforme	21138945	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21364760	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	22581003	CNVD
Glioblastoma multiforme	21390271	CNVD
Acute lymphoblastic leukemia	20699438	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	21990379	CNVD

Chromatin state (count:475 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:47993400-48001400	Weak transcription	Right Atrium	heart
2	chr11:47996400-48001200	Weak transcription	Brain Hippocampus Middle	brain
3	chr11:47996400-48001400	Enhancers	Primary neutrophils fromperipheralblood	blood
4	chr11:47996400-48001400	Weak transcription	Stomach Mucosa	stomach
5	chr11:47996400-48001600	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
6	chr11:47996400-48001600	Weak transcription	Fetal Lung	lung
7	chr11:47996600-48001200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
8	chr11:47996600-48001200	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
9	chr11:47996600-48001200	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
10	chr11:47996600-48001200	Weak transcription	Fetal Kidney	kidney
11	chr11:47996600-48001400	Weak transcription	Adipose Nuclei	Adipose
12	chr11:47996600-48001400	Weak transcription	Skeletal Muscle Male	skeletal muscle
13	chr11:47996600-48001400	Weak transcription	GM12878-XiMat	blood
14	chr11:47996600-48001400	Weak transcription	NHLF	lung
15	chr11:47996600-48001600	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
16	chr11:47996800-48001200	Weak transcription	NH-A	brain
17	chr11:47996800-48001400	Weak transcription	HSMM	muscle
18	chr11:47996800-48001600	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
19	chr11:47996800-48001600	Weak transcription	Muscle Satellite Cultured Cells	--
20	chr11:47996800-48001600	Weak transcription	Osteobl	bone
21	chr11:47997000-48001600	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
22	chr11:47997000-48001600	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
23	chr11:47997200-48001200	Weak transcription	Cortex derived primary cultured neurospheres	brain
24	chr11:47997400-48001600	Weak transcription	Lung	lung
25	chr11:47997800-48001200	Weak transcription	Placenta	Placenta
26	chr11:47999600-48001400	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
27	chr11:47999600-48001600	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
28	chr11:48000400-48001200	Enhancers	Primary B cells from cord blood	blood
29	chr11:48000400-48001400	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
30	chr11:48000400-48001400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
31	chr11:48000400-48001600	Enhancers	Primary B cells from peripheral blood	blood
32	chr11:48000600-48001200	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
33	chr11:48000600-48001200	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
34	chr11:48000600-48001200	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
35	chr11:48000600-48001400	Enhancers	Hela-S3	cervix
36	chr11:48000600-48001600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
37	chr11:48000600-48002000	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
38	chr11:48000800-48001200	Enhancers	HUES64 Cell Line	embryonic stem cell
39	chr11:48000800-48001200	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
40	chr11:48000800-48001200	Bivalent Enhancer	HepG2	liver
41	chr11:48000800-48001400	Enhancers	ES-WA7 Cell Line	embryonic stem cell
42	chr11:48000800-48001400	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
43	chr11:48000800-48001400	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
44	chr11:48000800-48001400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
45	chr11:48000800-48001400	Enhancers	Brain Substantia Nigra	brain
46	chr11:48000800-48001400	Bivalent Enhancer	Fetal Muscle Leg	muscle
47	chr11:48000800-48001600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
48	chr11:48000800-48001600	Enhancers	Primary T helper naive cells from peripheral blood	blood
49	chr11:48000800-48001600	Enhancers	Liver	Liver
50	chr11:48000800-48001600	Bivalent Enhancer	Fetal Thymus	thymus

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links